compound semaglutide ban π¨ FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compound versions of GLP-1 drugs
Description
Current evidence suggests that both semaglutide and tirzepatide require ongoing use for sustained weight maintenance
Is it ever safe to buy semaglutide without a prescription

Non-peptidic oral GLP-1RAs may eventually reduce supply pressures because they do not require peptide synthesis or cold-chain storage, but this will depend on scalable, cost-efficient manufacturing pathways

Its still widely available from peptide vendors (for better or for worse)

What documentation should a reputable supplier provide

Research on GLP-1 receptor agonists suggests that changes in muscle volume z-score, which accounts for body size, indicate adaptive rather than maladaptive responses to weight loss
